Risks and benefits of giving early Aspirin within 6 hours of CABG: A retrospective analysis

Area of Science:

• Cardiovascular Surgery
• Pharmacology

Background:

• Coronary artery bypass graft (CABG) surgery often requires antiplatelet therapy to prevent graft occlusion.
• Concerns about bleeding complications delay early post-operative antiplatelet administration, potentially reducing efficacy.
• Early antiplatelet use offers maximum benefit for graft patency.

Purpose of the Study:

• To evaluate the impact of early aspirin administration on bleeding complications after CABG.
• To assess the influence of early aspirin on blood transfusion requirements post-CABG.
• To determine the safety and efficacy of early aspirin in CABG patients.

Main Methods:

• Retrospective analysis of patients undergoing first-time CABG within three years.
• Comparison of bleeding complications and blood loss between patients receiving aspirin within 6 hours versus after 12 hours.
• Statistical analysis using SPSS, with P < 0.05 considered significant.

Main Results:

• 281 patients received early aspirin (within 6 hours), while 326 did not.
• Mean blood loss was 727ml in the early aspirin group vs. 767ml in the delayed group (p=0.74).
• No statistically significant difference in blood loss or transfusion units (median 2 units) between groups.

Conclusions:

• Early aspirin administration after CABG is safe and does not increase bleeding complications.
• Initiating aspirin early post-CABG can be done without heightened fear of bleeding.
• Early aspirin therapy may offer improved graft patency benefits without compromising patient safety.